Modeyso
Payments companies reported to CMS as associated with Modeyso. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Modeyso, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Modeyso
These are the largest totals companies reported as associated with Modeyso. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amanda Saratsis | Park Ridge, IL | Neurological Surgery | $143,700.00 |
| Yazmin Odia | Miami, FL | Neurology (Psychiatry & Neurology) | $15,392.60 |
| Ashley Sumrall | Charlotte, NC | Medical Oncology | $2,550.00 |
| Stephen Bagley | Philadelphia, PA | Hematology & Oncology | $2,040.00 |
| Edina Komlodi-Pasztor | Washington, DC | Neurology (Psychiatry & Neurology) | $1,950.60 |
| Nicole Shonka | Omaha, NE | Medical Oncology | $1,950.30 |
| Joe Mendez | Salt Lake City, UT | Neurological Surgery | $1,950.30 |
| Robert Yoo | Phoenix, AZ | Hematology & Oncology | $1,950.00 |
| Lindsay Kilburn | Houston, TX | Pediatric Hematology-Oncology | $1,950.00 |
| Nazanin Majd | Houston, TX | Neurology (Psychiatry & Neurology) | $1,950.00 |
Prescribed Modeyso?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.